Position in ZTS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$439,415,767
-$20,143,417 QoQ
Shares Held
3,717,247
+1.8% QoQ
Ownership
0.887%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 98.76860483040272.ToString("F0")%
Shared 0.ToString("F0")%
None 1.2313951695972851.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $1,628,257,886 across 43 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (27.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
3,717,247 | $439,415,767 | |
| 2 | VTRS |
Viatris Inc
|
13,674,306 | $184,739,874 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
300,481 | $178,179,223 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
902,788 | $118,933,291 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
3,577,850 | $85,617,950 | |
| 6 | ALKS |
Alkermes plc.
|
2,236,756 | $79,091,692 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,087,679 | $62,880,891 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
657,413 | $49,864,776 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $439,415,767 | 3,717,247 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $459,559,184 | 3,652,513 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $533,448,480 | 3,645,766 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $559,190,225 | 3,585,702 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $576,882,557 | 3,503,690 | Shares | Other | 2025-09-15 | |
| 2024-12-31 | $553,042,260 | 3,394,355 | Shares | Other | 2025-02-06 | |
| 2024-09-30 | $655,481,729 | 3,354,907 | Shares | Other | 2024-11-12 | |
| 2024-06-30 | $580,514,508 | 3,348,607 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $564,746,497 | 3,337,548 | Shares | Other | 2024-05-09 | |
| 2023-12-31 | $655,716,626 | 3,322,271 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $576,766,839 | 3,315,133 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $570,237,766 | 3,311,293 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $555,330,387 | 3,336,520 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $478,292,596 | 3,263,682 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $461,123,324 | 3,109,605 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $525,002,767 | 3,054,295 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $565,644,586 | 2,999,335 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $603,138,447 | 2,471,575 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $471,639,833 | 2,429,380 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $445,542,219 | 2,390,761 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $354,538,661 | 2,251,325 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $367,714,685 | 2,221,841 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $365,732,788 | 2,211,603 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $301,764,957 | 2,202,021 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $253,757,411 | 2,156,151 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||